Rusnati, M.; Bugatti, A.; Mitola, S.; Leali, D.; Bergese, P.; Depero, L.E.; Presta, M.
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity. Sensors 2009, 9, 6471-6503.
https://doi.org/10.3390/s90806471
AMA Style
Rusnati M, Bugatti A, Mitola S, Leali D, Bergese P, Depero LE, Presta M.
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity. Sensors. 2009; 9(8):6471-6503.
https://doi.org/10.3390/s90806471
Chicago/Turabian Style
Rusnati, Marco, Antonella Bugatti, Stefania Mitola, Daria Leali, Paolo Bergese, Laura E. Depero, and Marco Presta.
2009. "Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity" Sensors 9, no. 8: 6471-6503.
https://doi.org/10.3390/s90806471
APA Style
Rusnati, M., Bugatti, A., Mitola, S., Leali, D., Bergese, P., Depero, L. E., & Presta, M.
(2009). Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity. Sensors, 9(8), 6471-6503.
https://doi.org/10.3390/s90806471
